Following the World Health Organisation's allegation that another cough syrup made in India was found to be contaminated, the manufacturer in Punjab reacted to the development.
Sudhir Pathak, MD of QP Pharmachem Ltd told news agency ANI that the authorities suspect that someone may have duplicated the cough syrup in Cambodia. From Cambodia, the fake Guaifenesin Syrup TG Syrup may have been sent to the Marshall Islands and Micronesia, he claimed.
Pathak added that this could be an attempt to defame India.
The WHO on April 25, 2023, said that a batch of substandard Guaifenesin Syrup TG Syrup was found in the Marshall Islands, and the Federated States of Micronesia. WHO said that the cough syrup had unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.